<DOC>
	<DOCNO>NCT00071552</DOCNO>
	<brief_summary>The primary objective study evaluate effect Beclomethasone dipropionate HFA small airway compare Fluticasone propionate powder inhalation administer twice daily poorly control asthmatic .</brief_summary>
	<brief_title>Efficacy QVAR v Flovent Diskus Small Airways Poorly Controlled Asthmatic Adolescents/Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Poorly control asthma ; Average use 2 puff albuterol per day previous 7 day OR Having symptom asthma 5 last 7 day OR Awakening night due asthma least previous 7 day OR Having treat course oral intravenous steroid least last 3 month . Subjects receive escalate dos immunotherapy , oral immunotherapy short course ( rush ) immunotherapy rhinitis ; Requires betablockers , MAO inhibitor , tricyclic antidepressant , oral intranasal anticholinergic ; History and/or presence nonasthmatic acute chronic lung disease , include limited bronchitis , emphysema , active tuberculosis , bronchiectasis cystic fibrosis ; History and/or presence clinically significant cardiovascular disease , clinically significant hepatic , renal , endocrine dysfunction , stroke , uncontrolled diabetes , hyperthyroidism , convulsive disorder , neoplastic disease basal cell carcinoma , significant psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Poorly Controlled Asthma</keyword>
</DOC>